Study identifies potential immunotherapy strategy for early-stage prostate cancer
February 26, 2026
February 26, 2026
ROCHESTER, Minnesota, Feb. 26 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Study identifies potential immunotherapy strategy for early-stage prostate cancer
*
PHOENIX -A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage . . .
* * *
Study identifies potential immunotherapy strategy for early-stage prostate cancer
*
PHOENIX -A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage . . .